Moderna Total Depreciation and Amortization - Cash Flow 2017-2025 | MRNA
Moderna total depreciation and amortization - cash flow for the twelve months ending March 31, 2025 was $189M, a 82.63% decline year-over-year.
- Moderna annual total depreciation and amortization - cash flow for 2024 was $0.094B, a 83.21% decline from 2023.
- Moderna annual total depreciation and amortization - cash flow for 2023 was $0.56B, a 47.76% increase from 2022.
- Moderna annual total depreciation and amortization - cash flow for 2022 was $0.379B, a 32.52% increase from 2021.